These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 20548334)
21. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Wang Z; Liu M; Zhu H; Zhang W; He S; Hu C; Quan L; Bai J; Xu N Mol Carcinog; 2013 Aug; 52(8):634-46. PubMed ID: 22431000 [TBL] [Abstract][Full Text] [Related]
22. The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Li W; Jin X; Deng X; Zhang G; Zhang B; Ma L Biochem Biophys Res Commun; 2014 Jun; 449(2):235-40. PubMed ID: 24845562 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm. Yin LH; Zheng XQ; Li HY; Bi LX; Shi YF; Ye AF; Wu JB; Gao SM Leuk Res; 2015 Apr; 39(4):471-8. PubMed ID: 25666256 [TBL] [Abstract][Full Text] [Related]
24. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Li XF; Yan PJ; Shao ZM Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247 [TBL] [Abstract][Full Text] [Related]
26. miR-126 functions as a tumour suppressor in human gastric cancer. Feng R; Chen X; Yu Y; Su L; Yu B; Li J; Cai Q; Yan M; Liu B; Zhu Z Cancer Lett; 2010 Dec; 298(1):50-63. PubMed ID: 20619534 [TBL] [Abstract][Full Text] [Related]
27. Decreased expression of microRNA-143 and -145 in human gastric cancers. Takagi T; Iio A; Nakagawa Y; Naoe T; Tanigawa N; Akao Y Oncology; 2009; 77(1):12-21. PubMed ID: 19439999 [TBL] [Abstract][Full Text] [Related]
28. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366 [TBL] [Abstract][Full Text] [Related]
29. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139 [TBL] [Abstract][Full Text] [Related]
30. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Luo H; Zou J; Dong Z; Zeng Q; Wu D; Liu L Biochem J; 2012 Mar; 442(2):311-21. PubMed ID: 22132820 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Liu T; Tang H; Lang Y; Liu M; Li X Cancer Lett; 2009 Jan; 273(2):233-42. PubMed ID: 18789835 [TBL] [Abstract][Full Text] [Related]
32. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213 [TBL] [Abstract][Full Text] [Related]
34. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1. Shen X; Si Y; Yang Z; Wang Q; Yuan J; Zhang X Med Oncol; 2015 Jan; 32(1):361. PubMed ID: 25432696 [TBL] [Abstract][Full Text] [Related]
36. miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc. He W; Li Y; Chen X; Lu L; Tang B; Wang Z; Pan Y; Cai S; He Y; Ke Z J Gastroenterol Hepatol; 2014; 29(7):1427-34. PubMed ID: 24612089 [TBL] [Abstract][Full Text] [Related]
37. Deregulated expression of miR-145 in manifold human cancer cells. Xing AY; Wang B; Shi DB; Zhang XF; Gao C; He XQ; Liu WJ; Gao P Exp Mol Pathol; 2013 Aug; 95(1):91-7. PubMed ID: 23714355 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of miR-146a in gastric cancer cases. Kogo R; Mimori K; Tanaka F; Komune S; Mori M Clin Cancer Res; 2011 Jul; 17(13):4277-84. PubMed ID: 21632853 [TBL] [Abstract][Full Text] [Related]
39. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. Zhou J; Tian Y; Li J; Lu B; Sun M; Zou Y; Kong R; Luo Y; Shi Y; Wang K; Ji G Biochem Biophys Res Commun; 2013 Apr; 433(2):207-12. PubMed ID: 23466356 [TBL] [Abstract][Full Text] [Related]
40. MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation. Wu H; Huang M; Cao P; Wang T; Shu Y; Liu P Cancer Biol Ther; 2012 Mar; 13(5):281-8. PubMed ID: 22310976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]